{'text': 'Loss in MCL-1 function sensitizes non-Hodgkin’s lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)', 'publisher': {'href': 'https://www.nature.com', 'title': 'Nature.com'}, 'created_at': 'Fri, 13 Nov 2015 08:00:00 GMT', 'description': 'Loss in MCL-1 function sensitizes non-Hodgkin’s lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)  Nature.com', 'url': 'https://news.google.com/rss/articles/CBMiU0FVX3lxTE9fNnMwV2JwT1pWU0Njd3p3dHJKX09YUk1ibDRxLXZHQlFUbGt5S3BGLUJ3NUxjWGU0dVZGWVBDZlN4RWNvNXZIR1B2WlpIUDhyMlp3?oc=5&hl=en-US&gl=US&ceid=US:en'}
